New rules for non-UPC funded medicines from Dec 7

AI executive summary
The story at a glance, best enjoyed with a coffee ☕
The Ministry of Health announced that starting Monday, December 7, 2026, Resolution 1816 of 2026 will be fully implemented, establishing new rules for managing medicines, health technologies, and complementary services not financed with resources from the Payment per Capitation Unit (UPC). The measure modifies procedures related to access, prescription, supply, verification, control, payment, and information analysis of these technologies and services. Until December 6, the procedures established in Resolutions 740 and 2622 of 2024 will remain in effect, allowing a transition period for entities to make necessary adjustments. The Health portfolio also reported that it will make adjustments to the MIPRES platform, a tool used by health professionals to register medical prescriptions.
🔔 Sign in to follow this story and get its updates.
In this story you will find
AI analysis
Why it matters
These new rules will directly affect patients who require medicines or services not financed with UPC, as well as EPS, IPS, providers, and health professionals who participate in these processes. The measure seeks to guarantee more efficient and transparent access to these technologies.
▸▾ Rate, add sources or report this story
Sign in to rate this story and add sources.
Community annexes
Coverage of this same story by other outlets, contributed by readers and checked automatically.
Ask about this coverage
Get an AI answer grounded in reports from different outlets, with links to the sources.